[1] 王永华, 吴庭苗. 经导管肝动脉化疗栓塞术联合125I放射性粒子治疗肝癌的临床应用现状及进展. 中华核医学与分子影像杂志, 2019, 39:112-115.
[2] 武中林, 李智岗, 吴晓云, 等. 经导管肝动脉栓塞与肝动脉灌注化疗栓塞在原发性肝癌介入治疗中的远期疗效比较. 中国全科医学, 2016, 19:1292-1296.
[3] Chen J, Huang J, Chen M, et al. Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients. J Cancer, 2017, 8:2984-2991.
[4] 吕东来, 陆林, 卢虎生,等. 三维适形放射治疗原发性肝癌患者发生放射性肝损伤相关因素分析. 实用肝脏病杂志, 2017, 20:89-92.
[5] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 中华肝脏病杂志, 2012, 20:929-946.
[6] Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis, 2010, 30:52-60.
[7] 陈冬, 王仁本. 原发性肝癌外放疗临床应用现状. 中华肿瘤防治杂志, 2015, 22:76-80.
[8] Song B, Chung Y, Kim JA, et al. Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Cancer, 2015, 91:2386-2393.
[9] Lee HS, Kim JS, Choi IJ, et al. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer, 2015, 79:2087-2094.
[10] Weber HE, Dr?ge LH, Hennies S, et al. Volumetric intensity-modulated arc therapy vs. 3-dimensional conformal radiotherapy for primary chemoradiotherapy of anal carcinoma: Effects on treatment-related side effects and survival. Strahlenther Onkol, 2015, 191:827-834.
[11] 张立洁, 彭泉, 芦东徽,等. 三维适形放疗联合TACE治疗肝癌并发门静脉癌栓疗效的Meta分析. 实用肝脏病杂志, 2015, 18:254-257.
[12] 王小礼, 刘希军, 孟英涛. 肝动脉介入治疗联合三维适形放疗对伴癌栓原发性肝癌的效果分析. 肿瘤研究与临床, 2015, 27:840-842.
[13] Tan X, Xie P, Liu J, et al. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study. Asia Pac J Clin Oncol, 2015, 11:6-12.
[14] Paik EK, Kim MS, Jang WI, et al. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma. Radiat Oncol, 2016, 11:22-29.
[15] 王征夏, 尹思能, 索运生. 三种不同方式治疗原发性肝癌患者的远期预后对比分析. 西部医学, 2019, 31:1061-1066. |
